^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Rhabdomyosarcoma
    Drug:doxorubicin hydrochloride (Topoisomerase II inhibitor) +
    cyclophosphamide (Alkylating agent) +
    ifosfamide (Bifunctional alkylating agent) +
    vincristine (Tubulin polymerization inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Rhabdomyosarcoma: Preferred Regimens…Vincristine, dactinomycin, cyclophosphamide alternating with ifosfamide and etoposide